Published on 18 Jun 2024 on Simply Wall St. · via Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Could Be 36% Below Their Intrinsic...
Key Insights
The projected fair value for ADMA Biologics is US$16.66 based on 2 Stage Free Cash Flow to EquityADMA Biologics is estimated to be 36% undervalued based on current share price of US$10.63Our fair value estimate is 59% higher than ADMA Biologics' analyst price target of US$10.50
In this article we are going to estimate the intrinsic value of ADMA Biologics, Inc. (NASDAQ:ADMA) by taking the forecast future cash flows of the company and discounting them back to today's value. This will be done using the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.